Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes
Shinji Kume,
Motoyuki Kondo,
Shiro Maeda,
Yoshihiko Nishio,
Tsuyoshi Yanagimachi,
Yukihiro Fujita,
Masakazu Haneda,
Keiko Kondo,
Akihiro Sekine,
Shin-ich Araki,
Hisazumi Araki,
Masami Chin-Kanasaki,
Satoshi Ugi,
Daisuke Koya,
Sawako Kitahara,
Kiyosumi Maeda,
Atsunori Kashiwagi,
Takashi Uzu,
Hiroshi Maegawa
Affiliations
Shinji Kume
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Motoyuki Kondo
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Shiro Maeda
Laboratory for Endocrinology and Metabolism, RIKEN Center for Genomic Medicine, Yokohama, Kanagawa 230-0045, Japan
Yoshihiko Nishio
Division of Diabetes, Metabolism and Endocrinology, Kagoshima University Graduate School of Medical and Dental Sciences, Sakuragaoka, Kagoshima 890-8580, Japan
Tsuyoshi Yanagimachi
Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan
Yukihiro Fujita
Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan
Masakazu Haneda
Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan
Keiko Kondo
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Akihiro Sekine
Chiba University, Center for Preventive Medical Science. 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-0856, Japan
Shin-ich Araki
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Hisazumi Araki
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Masami Chin-Kanasaki
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Satoshi Ugi
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Daisuke Koya
Division of Diabetology & Endocrinology, Kanazawa Medical University, Kahoku-gun, Ishikawa 920-1192, Japan
Sawako Kitahara
Kusatsu General Hospital, Kusatsu, Shiga 525-0066, Japan
Kiyosumi Maeda
Kusatsu General Hospital, Kusatsu, Shiga 525-0066, Japan
Atsunori Kashiwagi
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Takashi Uzu
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Hiroshi Maegawa
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
Glucose-stimulated insulin secretion (GSIS) by pancreatic β cells is biphasic. However, the physiological significance of biphasic GSIS and its relationship to diabetes are not yet fully understood. This study demonstrated that impaired first-phase GSIS follows fasting, leading to increased blood glucose levels and brain glucose distribution in humans. Animal experiments to determine a possible network between the brain and β cells revealed that fasting-dependent hyperactivation of AMP-activated protein kinase in the hypothalamus inhibited first-phase GSIS by stimulating the α-adrenergic pancreatic nerve. Furthermore, abnormal excitability of this brain-β cell neural axis was involved in diabetes-related impairment of first-phase GSIS in diabetic animals. Finally, pancreatic denervation improved first-phase GSIS and glucose tolerance and ameliorated severe diabetes by preventing β cell loss in diabetic animals. These results indicate that impaired first-phase GSIS is critical for brain distribution of dietary glucose after fasting. Furthermore, β cells in individuals with diabetes mistakenly sense that they are under conditions that mimic prolonged fasting. The present study provides additional insight into both β cell physiology and the pathogenesis of β cell dysfunction in type 2 diabetes.